Dr. Samuel G. Levy Co-Founded Allurion Technologies, Inc. in 2009 and serves as its President and Director. Dr. Levy is a former McKinsey & Co. consultant and Fulbright scholar. He has been a Director of Theraclion, S.A.S. since May 12, 2016. He graduated summa cum laude and Phi Beta Kappa from Yale College with a B.S. in Molecular Biophysics and Biochemistry. He graduated from Harvard Medical School in 2012.